Ebos Shakes Bear Following Post-Results Selloff -- Market Talk

Dow Jones

2025/09/19

0100 GMT - Pharmaceutical supplier Ebos shakes its bear at Citi following the recent sharp selloff in its stock. With the stock down by more than 25% since the dual-listed company reported its annual results on Aug. 27, the investment bank raises its recommendation to neutral from sell. Analyst Laura Sutcliffe says shares are now trading at about 17 times estimated FY 2027 core earnings, which is close to their historical average. She sets her target price a little lower to reflect the softer-than-expected margins reported last month. Citi cuts its target price on Ebos's Australia-listed stock by 12.5% to A$28.00. Shares are up 3.0% at A$26.15. (stuart.condie@wsj.com)

(END) Dow Jones Newswires

September 18, 2025 21:00 ET (01:00 GMT)

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2568287109"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2568287109\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2568287109?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-19 09:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2568287109","market":"hk","top_or_hot":-1,"title":"Ebos Shakes Bear Following Post-Results Selloff -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0100 GMT - Pharmaceutical supplier Ebos shakes its bear at Citi following the recent sharp selloff in its stock. With the stock down by more than 25% since the dual-listed company reported its annual results on Aug. 27, the investment bank raises its recommendation to neutral from sell. Analyst Laura Sutcliffe says shares are now trading at about 17 times estimated FY 2027 core earnings, which is close to their historical average. She sets her target price a little lower to reflect the softer-than-expected margins reported last month. Citi cuts its target price on Ebos's Australia-listed stock by 12.5% to A$28.00. Shares are up 3.0% at A$26.15. (stuart.condie@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  September 18, 2025 21:00 ET (01:00 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ebos Shakes Bear Following Post-Results Selloff -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEbos Shakes Bear Following Post-Results Selloff -- Market Talk\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2025-09-19 09:00</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0100 GMT - Pharmaceutical supplier Ebos shakes its bear at Citi following the recent sharp selloff in its stock. With the stock down by more than 25% since the dual-listed company reported its annual results on Aug. 27, the investment bank raises its recommendation to neutral from sell. Analyst Laura Sutcliffe says shares are now trading at about 17 times estimated FY 2027 core earnings, which is close to their historical average. She sets her target price a little lower to reflect the softer-than-expected margins reported last month. Citi cuts its target price on Ebos's Australia-listed stock by 12.5% to A$28.00. Shares are up 3.0% at A$26.15. (stuart.condie@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  September 18, 2025 21:00 ET (01:00 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"POST","symbol_name":"Post Holdings","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2568287109","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2568287109","pubTimestamp":1758243600,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0100 GMT - Pharmaceutical supplier Ebos shakes its bear at Citi following the recent sharp selloff in its stock. With the stock down by more than 25% since the dual-listed company reported its annual results on Aug. 27, the investment bank raises its recommendation to neutral from sell. Analyst Laura Sutcliffe says shares are now trading at about 17 times estimated FY 2027 core earnings, which is close to their historical average. She sets her target price a little lower to reflect the softer-than-expected margins reported last month. Citi cuts its target price on Ebos's Australia-listed stock by 12.5% to A$28.00. Shares are up 3.0% at A$26.15. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"POST":"Post Holdings","BK8046":"保健护理产品经销商","BK7103":"保健护理产品经销商","EBO.AU":"EBOS GROUP LIMITED","BK4212":"包装食品与肉类","EBO.NZ":"Ebos Group Limited Ordinary Shares"},"translate_title":"Ebos在业绩公布后抛售后摆脱熊市——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EBO.NZ":0.9,"POST":1.5,"EBO.AU":0.9},"content_text":"0100 GMT - Pharmaceutical supplier Ebos shakes its bear at Citi following the recent sharp selloff in its stock. With the stock down by more than 25% since the dual-listed company reported its annual results on Aug. 27, the investment bank raises its recommendation to neutral from sell. Analyst Laura Sutcliffe says shares are now trading at about 17 times estimated FY 2027 core earnings, which is close to their historical average. She sets her target price a little lower to reflect the softer-than-expected margins reported last month. Citi cuts its target price on Ebos's Australia-listed stock by 12.5% to A$28.00. Shares are up 3.0% at A$26.15. (stuart.condie@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 18, 2025 21:00 ET (01:00 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}